-
Posted by
Two Blokes Jun 16 -
Filed in
Stock
-
6 views
Toronto, Ontario--(Newsfile Corp. - June 16, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously approved drugs, is announcing that Rob Steen has resigned as CEO and from the board of directors of the Company effective immediately. Chairman David Kideckel will step into the role of Executive Chairman and will assume Rob's responsibilities until the Company has found and hired a suitable replacement.
